# LA137-2

# None

# Active

## Answer Lists using this Answer Code

Answer List | Answer List Name | Externally Defined |
---|---|---|

LL1015-8 | [PROMIS] None| |
N |

LL1018-2 | [PROMIS] None| |
N |

LL1148-7 | PhenX08_15_natural teeth amt | N |

LL1162-8 | Quantity (5 answers, ord) | N |

LL1173-5 | PhenX09_12_wheezing amt | N |

LL1230-3 | PhenX10_41_ night urination freq | N |

LL124-9 | CR_1646_Surgery site | N |

LL1245-1 | PhenX11_07_child strabismus tx | N |

LL1246-9 | PhenX11_08_myopia tx | N |

LL1349-1 | PhenX12_79_morning, evening preference | N |

LL1375-6 | PhenX13_10_sensory symptoms | N |

LL1376-4 | PhenX13_11_ motor symptoms | N |

LL1377-2 | PhenX13_12_motor symptoms, arms | N |

LL1423-4 | PhenX14_17_aids for walk | N |

LL1466-3 | PhenX07_31_exercise Hs | N |

LL1570-2 | PhenX13_47_body bradykinesia - hypokinesia | N |

LL1634-6 | PhenX18_17_fracture treatment | N |

LL1668-4 | PhenX19_14_hyperplastic polyps | N |

LL1671-8 | PhenX19_17_adenoma dysplasia | N |

LL1735-1 | FeedingType | N |

LL1736-9 | MaternalFactors | N |

LL1783-1 | Pediatric Coma Scale - Motor - <5Y | N |

LL1784-9 | Pediatric Coma Scale - Motor - >5Y | N |

LL1785-6 | Pediatric Coma Scale - Verbal - 0-23 Mos | N |

LL1786-4 | Pediatric Coma Scale - Verbal - 2-5 Ys | N |

LL1787-2 | Pediatric Coma Scale - Verbal - >5 Ys | N |

LL1818-5 | NEMSIS_31_adv directive | N |

LL1824-3 | NEMSIS_37_safety equipment | N |

LL1827-6 | NEMSIS_40_med complication | N |

LL1829-2 | NEMSIS_42_blood/fluid exposure | N |

LL1831-8 | NEMSIS_44_procedure complication | N |

LL1841-7 | NEMSIS_55_pts at scene | N |

LL1881-3 | NeuroQol_06 | N |

LL1883-9 | NEMSIS_72 | N |

LL1891-2 | FMQAI_12_Payment source | N |

LL1966-2 | PhenX14_36_amount of dextrose consumed | N |

LL2001-7 | NEMSIS_84_environ allergies | N |

LL2089-2 | None| |
N |

LL2094-2 | NBS Hb | N |

LL2155-1 | VA-36-body pain | N |

LL2194-0 | RHEA - person attending birth | N |

LL2221-1 | Dressing purposes | N |

LL227-0 | CR_670_Surgical protocol | N |

LL2273-2 | Resp viruses | N |

LL235-3 | CR_920_Pathology descriptor | N |

LL241-1 | CR_980_Clincial staging descriptor | N |

LL2871-3 | None| |
N |

LL3065-1 | None| |
N |

LL3132-9 | IEEE_heater type | N |

LL3180-8 | 20150106-APTASet1_3 | N |

LL3181-6 | 20150106-APTASet1_4 | N |

LL3187-3 | 20150106-APTASet1_10 | N |

LL3189-9 | 20150106-APTASet1_12 | N |

LL3190-7 | 20150106-APTASet1_13 | N |

LL3191-5 | 20150106-APTASet1_14 | N |

LL3195-6 | 20150106-APTASet1_18 | N |

LL3258-2 | APTA AnswerLists | N |

LL34-0 | MDS_1441_MDS proportion | N |

LL3509-8 | UPDRS_Intellectual impairment | N |

LL351-8 | ART_2_Prior | N |

LL3510-6 | UPDRS_Thought disorder | N |

LL3511-4 | UPDRS_Depression | N |

LL3522-1 | UPDRS_Freezing when walking | N |

LL3525-4 | UPDRS_Sensory complaints related to parkinsonism | N |

LL3537-9 | UPDRS_Ave proportion waking day patient is "off" | N |

LL3600-5 | None| |
N |

LL3638-5 | Heparin| |
N |

LL3649-2 | UPDRS_Body bradykinesia and hypokinesia | N |

LL3686-4 | Diseased coronary segment categories | N |

LL37-3 | MDS_1612_Avg time in activities | N |

LL3729-2 | [NEI] Gross eye defects | N |

LL3734-2 | [NEI] Oculary history | N |

LL3736-7 | [NEI] Previous ophthalmologic treatment | N |

LL3738-3 | [NEI] Strabismus type | N |

LL3739-1 | [NEI] Ophthalmologic disease related systemic find | N |

LL3740-9 | [NEI] Tetraparesis type | N |

LL3741-7 | [NEI] Tissue types positive for axonal spheroids | N |

LL3758-1 | [NEI] Visual field defect findings | N |

LL3764-9 | [NEI] Chorioretinal findings | N |

LL3765-6 | [NEI] Macula exam findings | N |

LL3773-0 | [NEI] Anterior chamber slit lamp findings | N |

LL3774-8 | [NEI] Conjunctiva and sclera slit lamp findings | N |

LL3775-5 | [NEI] Cornea slit lamp findings | N |

LL3776-3 | [NEI] Iris slit lamp findings | N |

LL3777-1 | [NEI] Lens slit lamp findings | N |

LL3779-7 | [NEI] Lids and lashes slit lamp findings | N |

LL3781-3 | [NEI] Vitreous slit lamp findings | N |

LL3799-5 | 20150908-MAYO_3 | N |

LL3882-9 | [APTA] Surgery relevant to physical therapy | N |

LL3943-9 | Absent | |
N |

LL395-5 | QAM_6_Fear-anxiety | N |

LL3961-1 | None | |
N |

LL3982-7 | None| |
N |

LL4044-5 | S282T | |
N |

LL4051-0 | None(0)| |
N |

LL4071-8 | Short course| |
N |

LL4100-5 | [ALSFRS-R] Dyspnea | N |

LL4101-3 | [ALSFRS-R] Orthopnea | N |

LL4102-1 | [ALSFRS-R] Respiratory insufficiency | N |

LL4123-7 | PCORI_Smoked_v_non-smoked_tobacco | N |

LL4135-1 | Platelet aggregation inhibitors | N |

LL4136-9 | Anticoagulant medications | N |

LL4137-7 | Preoperative procedures | N |

LL4146-8 | LL4146-8 | N |

LL4160-9 | LL4160-9 | N |

LL43-1 | MDS_1942_Significant other participation | N |

LL4371-2 | CAP_lymphocytic response | N |

LL4478-5 | None| |
N |

LL456-5 | CR_690_Radiation treatment | N |

LL457-3 | CR_720_Transplant treatment | N |

LL4578-2 | Birth control methods | N |

LL458-1 | CR_700_Chemo treatment | N |

LL459-9 | CR_710_Hormone treatment | N |

LL4629-3 | NTDB_Cerebral Monitor | N |

LL4650-9 | Sufficient| |
N |

LL4656-6 | Minimal| |
N |

LL4671-5 | UPDRS_Falling | N |

LL4675-6 | Treatments or procedures for abnormal Pap | N |

LL4697-0 | None| |
N |

LL4748-1 | NTDS_ED_17_Drug Screen | N |

LL4752-3 | NTDS_I_14_Protective devices | N |

LL488-8 | DEEDS4.14_1st GCS-eye | N |

LL4883-6 | KOOS | N |

LL489-6 | DEEDS4.15_1st GCS-verbal | N |

LL490-4 | DEEDS4.16_1st GCS-motor | N |

LL4999-0 | Circulatory assistive devices | N |

LL5003-0 | Eog admin assistance | N |

LL5014-7 | APTA_Assistive technology | N |

LL5016-2 | APTA_Instruction provided | N |

LL5018-8 | APTA_Biophysical agent | N |

LL5073-3 | Treatment on specimen | N |

LL5076-6 | Amount of meal eaten | N |

LL5200-2 | [PUSH 3.0] Exudate amount | N |

LL5254-9 | Endemic Diseases | N |

LL5318-2 | Never | |
N |

LL5322-4 | Resistance conferred by variant | N |

LL5473-5 | None| |
N |

LL5496-6 | Religious belief | N |

LL552-1 | CARE_3_Da_Current Medical Information | N |

LL5533-6 | None| |
N |

LL5539-3 | none| |
N |

LL559-6 | CARE_4_b03a_Three words first repetition | N |

LL574-5 | CARE_5_B1_Swallowing Disorder | N |

LL5764-7 | None| |
N |

LL5793-6 | None/A little/Quite a lot/Extreme | N |

LL58-9 | CR_1050_Descriptor stage | N |

LL5817-3 | None/More than 21 days | N |

LL5828-0 | Spine Tango - Therapeutic goals/measures | N |

LL5829-8 | Spine Tango - Meds Spinal surgery/pathology | N |

LL5833-0 | Spine Tango - Therapeutic consequences | N |

LL5834-8 | Sping Tango - Individual Consequences | N |

LL5835-5 | Spine Tango - Rehabilitation | N |

LL5880-1 | Hours per day | N |

LL5896-7 | EuroSpine - Pathologies | N |

LL5902-3 | EuroSPine - Components | N |

LL5911-4 | Blood transfusion | N |

LL5912-2 | Decompression | N |

LL5915-5 | Fusion material | N |

LL5916-3 | EuroSpine - Stabilized rigid | N |

LL5917-1 | Deformity correction | N |

LL5918-9 | Stabilization motion preserving | N |

LL5919-7 | Other surgial measures | N |

LL5920-5 | Intraop adverse event | N |

LL5921-3 | Measures during index surgery | N |

LL5922-1 | Intraop general complications | N |

LL5923-9 | PostOp Surgical Complications | N |

LL5924-7 | PostOp General Complications | N |

LL5925-4 | Re-intervention after index surgery | N |

LL5961-9 | Spine Tango - Degeneration Type_Secondary | N |

LL5968-4 | Spine Fusion Measures | N |

LL6009-6 | Encephalopathy Grades | N |

LL6043-5 | None| |
N |

LL6045-0 | None| |
N |

LL6046-8 | None| |
N |

LL6050-0 | Therapeutic Antibody Treatment | N |

LL61-3 | CR_1090_Metastasis site | N |

LL6111-0 | Lysholm - Limp | N |

LL6112-8 | Lysholm -Support | N |

LL6120-1 | Lysholm - Pain | N |

LL6121-9 | Lysholm - Swelling | N |

LL6174-8 | Medial lateral instability | N |

LL6175-5 | Anterior posterior instability | N |

LL6213-4 | NOMS FCMS Swallow Daily Diet | N |

LL6228-2 | Harris Hip Score - Support | N |

LL6235-7 | Harris Hip Score - Limp | N |

LL6239-9 | Medial / Lateral Instability | N |

LL6240-7 | Anterior / Posterior Instability | N |

LL6286-0 | Protease failed codons | N |

LL6340-5 | PAINAD negative vocalization | N |

LL66-2 | CR_1130_Peds staging coding system | N |

LL670-1 | MDSv3_J1900A | N |

LL687-5 | MDSv3_C0200 | N |

LL722-0 | CARE_1_A3_Other medical services | N |

LL755-0 | howRU | N |

LL830-1 | NBS events | N |

LL835-0 | NBS conditions | N |

LL837-6 | NBS AA susc | N |

LL838-4 | NBS FA susc | N |

LL839-2 | NBS OA susc | N |

LL862-4 | NBS_hear_risk | N |

LL91-0 | CR_1360_Radiation summary | N |

LL94-4 | CR_1390_Chemo | N |

LL96-9 | CR_1400_Hormone treatment | N |

LL97-7 | CR_1400_V9_Hormaine treatment summary | N |

LL98-5 | CR_1410_BRM treatment | N |

## LOINC Copyright

Copyright © 2023 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright